Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer

Fig. 2

Survival analysis of ZBTB4 expression based on The Cancer Genome Atlas database. A–L ZBTB4 expression in ACC (A), BLCA (B), DLBC (C), GBMLGG (D), HNSC (E), KIPAN (F), KIRC (G), LUAD (H), LUSC (I), MESO (J), OV (K) and PAAD (L) was analyzed using the Kaplan–Meier method in relation to overall survival (OS). (M–X) The relationship between ZBTB4 expression and disease-specific survival (DSS) in ACC (M), GBMLGG (N), HNSC (O), KIPAN (P), KIRC (Q), KIRP (R), LUAD (S), LUSC (T), MESO (U), PAAD (V), PCPG (W) and UVM (X) was subsequently analyzed using the Kaplan–Meier method as well. Red is low expression and blue is high expression

Back to article page